98 related articles for article (PubMed ID: 22535468)
1. Predictors of thromboxane levels in patients with non-ST-elevation acute coronary syndromes on chronic aspirin therapy.
Niccoli G; Giubilato S; Leo A; Cosentino N; Fracassi F; Cataneo L; Porto I; Leone AM; Burzotta F; Trani C; Biasucci LM; Narducci ML; Pulcinelli FM; Crea F
Thromb Haemost; 2012 Jul; 108(1):133-9. PubMed ID: 22535468
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention.
Niccoli G; Giubilato S; Russo E; Spaziani C; Leo A; Porto I; Leone AM; Burzotta F; Riondino S; Pulcinelli F; Biasucci LM; Crea F
Eur Heart J; 2008 Aug; 29(15):1843-50. PubMed ID: 18617477
[TBL] [Abstract][Full Text] [Related]
3. Short- and long-term prognostic significance of ST-segment elevation in lead aVR in patients with non-ST-segment elevation acute coronary syndrome.
Taglieri N; Marzocchi A; Saia F; Marrozzini C; Palmerini T; Ortolani P; Cinti L; Rosmini S; Vagnarelli F; Alessi L; Villani C; Scaramuzzino G; Gallelli I; Melandri G; Branzi A; Rapezzi C
Am J Cardiol; 2011 Jul; 108(1):21-8. PubMed ID: 21529728
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of mean platelet volume on admission in an unselected cohort of patients with non ST-segment elevation acute coronary syndrome.
Taglieri N; Saia F; Rapezzi C; Marrozzini C; Bacchi Reggiani ML; Palmerini T; Ortolani P; Melandri G; Rosmini S; Cinti L; Alessi L; Vagnarelli F; Villani C; Branzi A; Marzocchi A
Thromb Haemost; 2011 Jul; 106(1):132-40. PubMed ID: 21614413
[TBL] [Abstract][Full Text] [Related]
5. Clinical correlates and prognostic value of flow mediated dilation in patients with non-ST segment elevation acute coronary syndromes.
Careri G; Nerla R; Di Monaco A; Russo G; Stazi A; Villano A; Sestito A; Lanza GA; Crea F
Am J Cardiol; 2013 Jan; 111(1):51-7. PubMed ID: 23062313
[TBL] [Abstract][Full Text] [Related]
6. Temporal changes in the management and outcome of Canadian diabetic patients hospitalized for non-ST-elevation acute coronary syndromes.
Elbarouni B; Ismaeil N; Yan RT; Fox KA; Connelly KA; Baer C; DeYoung JP; Gallo R; Ramanathan K; Pesant Y; Leiter LA; Goodman SG; Yan AT
Am Heart J; 2011 Aug; 162(2):347-355.e1. PubMed ID: 21835297
[TBL] [Abstract][Full Text] [Related]
7. Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome.
Bigalke B; Geisler T; Stellos K; Langer H; Daub K; Kremmer E; Seizer P; May AE; Lindemann S; Gawaz M
Am Heart J; 2008 Jul; 156(1):193-200. PubMed ID: 18585516
[TBL] [Abstract][Full Text] [Related]
8. B-type natriuretic peptide as an independent predictor of coronary disease extension in non-ST elevation coronary syndromes with preserved systolic function.
Palazzuoli A; Caputo M; Fineschi M; Navarri R; Calabrò A; Cameli M; Campagna MS; Franci B; Pierli C; Nuti R; Maisel A
Eur J Prev Cardiol; 2012 Jun; 19(3):366-73. PubMed ID: 21464097
[TBL] [Abstract][Full Text] [Related]
9. Disparities in management patterns and outcomes of patients with non-ST-elevation acute coronary syndrome with and without a history of cerebrovascular disease.
Lee TC; Goodman SG; Yan RT; Grondin FR; Welsh RC; Rose B; Gyenes G; Zimmerman RH; Brossoit R; Saposnik G; Graham JJ; Yan AT;
Am J Cardiol; 2010 Apr; 105(8):1083-9. PubMed ID: 20381657
[TBL] [Abstract][Full Text] [Related]
10. Residual platelet activity is increased in clopidogrel- and ASA-treated patients with coronary stenting for acute coronary syndromes compared with stable coronary artery disease.
Geisler T; Kapp M; Göhring-Frischholz K; Daub K; Dösch C; Bigalke B; Langer H; Herdeg C; Gawaz M
Heart; 2008 Jun; 94(6):743-7. PubMed ID: 17567647
[TBL] [Abstract][Full Text] [Related]
11. Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration.
Hedegaard SS; Hvas AM; Grove EL; Refsgaard J; Rocca B; Daví G; Kristensen SD
Thromb Res; 2009 May; 124(1):96-100. PubMed ID: 19215971
[TBL] [Abstract][Full Text] [Related]
12. A risk score to predict bleeding in patients with acute coronary syndromes.
Mehran R; Pocock SJ; Nikolsky E; Clayton T; Dangas GD; Kirtane AJ; Parise H; Fahy M; Manoukian SV; Feit F; Ohman ME; Witzenbichler B; Guagliumi G; Lansky AJ; Stone GW
J Am Coll Cardiol; 2010 Jun; 55(23):2556-66. PubMed ID: 20513595
[TBL] [Abstract][Full Text] [Related]
13. Regional patterns of use of a medical management strategy for patients with non-ST-segment elevation acute coronary syndromes: insights from the EARLY ACS Trial.
Roe MT; White JA; Kaul P; Tricoci P; Lokhnygina Y; Miller CD; van't Hof AW; Montalescot G; James SK; Saucedo J; Ohman EM; Pollack CV; Hochman JS; Armstrong PW; Giugliano RP; Harrington RA; Van de Werf F; Califf RM; Newby LK
Circ Cardiovasc Qual Outcomes; 2012 Mar; 5(2):205-13. PubMed ID: 22373905
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of admission heart failure in patients with non-ST-elevation acute coronary syndromes (from the Canadian Acute Coronary Syndrome Registries).
Segev A; Strauss BH; Tan M; Mendelsohn AA; Lai K; Ashton T; Fitchett D; Grima E; Langer A; Goodman SG;
Am J Cardiol; 2006 Aug; 98(4):470-3. PubMed ID: 16893699
[TBL] [Abstract][Full Text] [Related]
15. Platelet hyperfunction is decreased by additional aspirin loading in patients presenting with myocardial infarction on daily aspirin therapy.
Fuchs I; Spiel AO; Frossard M; Derhaschnig U; Riedmüller E; Jilma B
Crit Care Med; 2010 Jun; 38(6):1423-9. PubMed ID: 20400900
[TBL] [Abstract][Full Text] [Related]
16. Prior antiplatelet use and cardiovascular outcomes in patients presenting with acute coronary syndromes.
El-Menyar A; AlHabib KF; Al-Motarreb A; Hersi A; Al Faleh H; Asaad N; Al Saif S; Almahmeed W; Sulaiman K; Amin H; Al-Lawati J; Alsheikh-Ali AA; AlQahtani A; Al-Sagheer NQ; Singh R; Al Suwaidi J
Am J Cardiovasc Drugs; 2012 Apr; 12(2):127-35. PubMed ID: 22257172
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of pregnancy-associated plasma protein A in patients with acute coronary syndrome.
Iversen KK; Dalsgaard M; Teisner AS; Schoos M; Teisner B; Nielsen H; Clemmensen P; Grande P
Am J Cardiol; 2009 Dec; 104(11):1465-71. PubMed ID: 19932776
[TBL] [Abstract][Full Text] [Related]
18. Gender-related differences in the management of non-ST-elevation acute coronary syndrome patients.
Vikman S; Airaksinen KE; Tierala I; Peuhkurinen K; Majamaa-Voltti K; Niemelä M; Asplund S; Huhtala H; Niemelä K
Scand Cardiovasc J; 2007 Oct; 41(5):287-93. PubMed ID: 17852791
[TBL] [Abstract][Full Text] [Related]
19. The clinical importance of laboratory-defined aspirin resistance in patients presenting with non-ST elevation acute coronary syndromes.
Acikel S; Yildirir A; Aydinalp A; Bal U; Kaynar G; Ozin B; Muderrisoglu H
Blood Coagul Fibrinolysis; 2009 Sep; 20(6):427-32. PubMed ID: 19542882
[TBL] [Abstract][Full Text] [Related]
20. Circulating myeloid-related protein-8/14 is related to thromboxane-dependent platelet activation in patients with acute coronary syndrome, with and without ongoing low-dose aspirin treatment.
Santilli F; Paloscia L; Liani R; Di Nicola M; Di Marco M; Lattanzio S; La Barba S; Pascale S; Mascellanti M; Davì G
J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25037196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
